(Q37132862)

English

Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone

scientific article published on 27 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

1 reference

based on heuristic

inferred from title

15

object named as

Sagar Lonial

1 reference

Europe PubMed Central

18 August 2017

PMC publication ID

Kenneth C. Anderson

21

object named as

Kenneth C Anderson

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Pieter Sonneveld

14

object named as

Pieter Sonneveld

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Paul G. Richardson

7

object named as

Paul G Richardson

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Ruben Niesvizky

11

object named as

Ruben Niesvizky

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

12

object named as

Melissa Alsina

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Dixie-Lee Esseltine

18

object named as

Dixie-Lee Esseltine

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Jamie D Cavenagh

8

object named as

Jamie Cavenagh

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

9

object named as

Joan Bladé

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Helgi van de Velde

16

object named as

Helgi van de Velde

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1

object named as

David I Lichter

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

6

object named as

Hongliang Shi

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Deborah J Eaves

17

object named as

Deborah Ricci

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

William L Trepicchio

19

object named as

William L Trepicchio

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Hadi Danaee

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Michael D Pickard

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Olga Tayber

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Michael Sintchak

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Thierry Façon

10

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

William Dalton

13

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

George Mulligan

20

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

27 September 2012

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

120

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

23

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

4513-4516

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Inactivating PSMB5 mutations and P-glycoprotein (multidrug resistance-associated protein/ATP-binding cassette B1) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno)proteasome inhibitors in mononuclear blood cells from patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Molecular mechanisms of bortezomib resistant adenocarcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Proteasome system of protein degradation and processing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Protein degradation by the ubiquitin-proteasome pathway in normal and disease states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Controlling the false discovery rate in behavior genetics research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

The proteasome: paradigm of a self-compartmentalizing protease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Molecular structure of 20S and 26S proteasomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Studies on the yeast proteasome uncover its basic structural features and multiple in vivo functions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

14 September 2017

Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

3 September 2018

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

3 September 2018

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

3 September 2018

Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757460

3 September 2018

Proteasome inhibition measurements: clinical application

1 reference

https://pubmed.ncbi.nlm.nih.gov/23018640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2012-05-426924

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37132862&oldid=1856572582"